MedPath

Efficacy of Dexamethasone in reducing pain, nausea and vomiting, improve mobilisation and reduce hospital stay in hip and knee arthroplasty: a double blind controlled trial

Phase 4
Completed
Conditions
Hip Arthritis
Knee Arthritis
Musculoskeletal - Osteoarthritis
Surgery - Surgical techniques
Registration Number
ACTRN12615000540516
Lead Sponsor
Jonathan Mulford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
142
Inclusion Criteria

People who are presenting to preadmission clinic for single joint hip or knee arthroplasty.
-Able to provide informed consent
-Age 18 years and older

Exclusion Criteria

-Type 1 or type 2 diabetes mellitus; renal failure; hepatic failure
-Use of oral corticosteroids over past 6 months
-Allergic or adverse reaction to corticosteroids in the past
-Allergy to the food preservative Sulfite (this does not include Sulpha containing medications)
-Active peptic ulcer disease with symptoms present in the previous 6 months
-Previous GIT haemorrhage
-Pregnancy and lactation
-Past history of psychotic illness (including psychotic depression)
-Current systemic fungal infection
-Administration of live vaccine in the previous 3 months
-Myasthenia gravis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath